Patent · US Active

Combination therapies for the treatment of cancer

US11707448B2 · kind B2 · utility

0Cited by
15References
22Claims
0Family size

Assignee

Inventors

Key dates

Filing dateNov 17, 2021
Grant dateJul 25, 2023
Priority date
Expiry dateFeb 3, 2042

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2300/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides methods and compositions for treating cancer by administering an EP4 antagonist in combination with radiation therapy, antibody therapy and/or anti-metabolite chemotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.